Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) Stock Makes An Interesting Move: How To Trade Now
Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) stock was under pressure in the previous trading session after the recent news. The stock has lost over 20% over the past week.
Market Action
On Tuesday, KNOS stock closed down by 2.50% at $0.0390. More than 432k shares have exchanged hands, below its average volume of 910K shares. The stock opened at $0.0390 and moved in a range of $0.0360 – 0.0400.
KRONOS ADVANCED TECHNOLOGIES INC ACQUIRES MAJORITY INTEREST IN ZYPPAH INC
Here are the highlights:
Kronos Advanced Technologies announced today that the Company acquired the majority of shares of Zyppah Inc -the #1 marketed anti-snoring device manufacturer that has been granted the necessary clearances by the FDA for OTC (over-the-counter) distribution.
Zyppah, Inc. (“Happy Z “spelled backwards) was created by the preeminent U.S. expert on snoring and sleep apnea, Dr. Jonathan Greenburg, DDS.
Zyppah® is a patented, clinically proven, and FDA-cleared mouthpiece that is the only one that works in 2 unique ways. Primarily by advancing the lower jaw and, secondarily, utilizing a patented “seat belt for the tongue” to keep it from blocking the airways. This combination produced an impressive 91% success rate in clinical studies, while all competing solutions experienced less than a 50% success rate. NBA Hall of Famer and notorious former snorer Shaquille O’Neal, a happy success story declared the positive outcome utilizing Zyppah in an interview with Dr. Greenburg broadcast on the Dr. Oz Show.
Zyppah Inc is focused on the development, manufacturing, and commercialization of non-invasive oral, dental appliances and solutions that aid in the diagnosis of sleep disorders. The Company pioneered the Zyppah® Home anti-snoring device and provides sleep apnea appliances and training programs for patients, physicians, including dentists. The Zyppah® device is FDA-cleared and is the leading solution for snoring treatment as a safe and effective method.
Trader Notes:
KNOS stock has underperformed recently with a fall of over 52% in the past 6-month. On the technical basis, the stock is trading below its 200-Day SMA stand at $0.0677. Moreover, RSI at 50 signals that the stock is trading near the neutral zone.
